Amgen Inc. shares rose in the extended session Thursday after the biotech topped Wall Street estimates for the second quarter. Amgen shares advanced 1.9% to $175 on moderate volume. The company reported adjusted earnings of $2.57 a share on revenue of $5.37 billion. Analysts surveyed by FactSet had estimated $2.43 a share on revenue of $5.32 billion. Amgen said it expects adjusted 2015 earnings of $9.55 to $9.80 a share on revenue of $21.1 billion to $21.4 billion, while analysts surveyed expect earnings of $9.62 a share on revenue of $21.13 billion.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News